Toxoplasma gondii cylclic GMP dependent protein kinase G as a chemotherapeutic target for antiprotozoal agents
US7718390B2 · kind B2 · utility
0Cited by
2References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 2006 |
| Grant date | May 18, 2010 |
| Priority date | — |
| Expiry date | Aug 19, 2027 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/45
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Protozoal cyclic GMP dependent protein kinases have been isolated and cloned. These enzymes may be used in screening assays to identify potential antiprotozoal agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.